MedTrace Logo

My Mobile Advice Program: A Randomized Pilot Feasibility Study

NCT02136498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2017-11-13

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot study is to evaluate the acceptability and feasibility of the proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program).

Conditions

  • Smoking Cessation
  • Medication Adherence

Interventions

DRUG

Varenicline

Standard 12 week course of varenicline, provided in both arms

BEHAVIORAL

Cognitive-behavioral self-help

Standard self-help education for smoking cessation, delivered via mobile-optimized website accessible via smartphone.

BEHAVIORAL

MyMAP (My Mobile Advice Program)

Same standard self-help intervention as in control arm + automatically-tailored support and advice for managing nicotine withdrawal symptoms + secure messaging with cessation counselor

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Jennifer McClure, PhD · Group Health Research Institute

  • Sheryl Catz, PhD · University of California, Davis

  • Larry An, MD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136498 on ClinicalTrials.gov